CCWM
TRAW icon

Cassaday & Co Wealth Management’s Traws Pharma TRAW Stock Holding History

Cassaday & Co Wealth Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Sell
6
-5
-45% -$7 ﹤0.01% 1310
2026
Q1 		$21 Buy
+11
New +$21 ﹤0.01% 1355

Other funds holding TRAW

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Cassaday & Co Wealth Management's TRAW Position: Q2 2026 in Review

Cassaday & Co Wealth Management reduced its Traws Pharma (TRAW) stake by 45% in Q2 2026, selling an estimated $7 and leaving 6 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Cassaday & Co Wealth Management first reported a position in TRAW in Q1 2026 and has held it in 2 quarters since. The position peaked at $21 in Q1 2026. 35 funds tracked by Wall St. Rank hold TRAW as of Q2 2026.

  • Cassaday & Co Wealth Management held 6 shares of Traws Pharma worth $6 as of Q2 2026.
  • Cassaday & Co Wealth Management sold 5 Traws Pharma shares in Q2 2026, an estimated $7.
  • Traws Pharma made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #1310 holding.
  • Cassaday & Co Wealth Management first reported a position in Traws Pharma in Q1 2026 and has held it in 2 quarters since.
  • Cassaday & Co Wealth Management's Traws Pharma position peaked at $21 in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.